Diazepam (Diazepam) Patent Expiration, LOE Window & CMS Spending

Diazepam (Diazepam) by Us Army Medical Research Materiel Command: Off-Patent Genericized (AB Competition), 11 AB generics, $63.0M 2024 CMS Part D & Medicaid spend, and 4 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorUs Army Medical Research Materiel Command
FDA Application & PathwayN020124 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors11
2024 CMS Total Public Spend$63.0M
2024 Medicare Part D Spend$18.9M
2024 Medicaid Spend$44.1M
Reported Wholesale Price Change (CA SB 17)4 WAC filings (max 42.9% 2-yr change)